RxDoctor Payments Data

Christopher Discenna, PA

Physician Assistant · Rochester Hills, MINPI 1083198246

Payments from drug & device makers

$13,128in general payments, 2019–2025

Across 136 payments — averaging $96.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$10K
  • Tris Pharma Inc$779
  • Lundbeck LLC$620
  • Otsuka America Pharmaceutical, Inc.$462
  • Axsome Therapeutics, Inc.$379
  • Ironshore Pharmaceuticals Inc.$263
  • plus $951 from 10 others

What the payments were for

  • Speaking & faculty fees$9,00069%
  • Travel & lodging$3743%
  • Food & beverage$3,75429%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,128 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$5,683
Medicare patients
14
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole11$15,745
Venlafaxine Hcl ErVenlafaxine Hcl27$2,186
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine34$1,800
Bupropion XlBupropion Hcl35$1,421
Desvenlafaxine Succinate ErDesvenlafaxine Succinate12$561
Modafinil11$465
Fluoxetine Hcl18$436
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine24$365
Gabapentin15$255
Trazodone Hcl35$232
Quetiapine Fumarate11$223
Escitalopram Oxalate12$219
Lorazepam32$168
Lamotrigine13$164
Buspirone Hcl19$159

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$462$15,74511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Rochester Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →